All In Biotech

Drug Trial Radar · NCT07386938

A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast Cancer

International, Multicenter, Double-blind, Randomized, Comparative Study of Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® Drug Products Combined With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Metastatic or Locally Recurrent Unresectable Breast Cancer

Last checked: Nov 19, 2026Latest source record: Jul 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 246 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

246

Planned (sponsor's estimate)

Start

Aug 9, 2024

Primary completion

Oct 15, 2025

Study completion May 28, 2027

Sponsor

Lead sponsor
R-PharmIndustry
Sponsor type
Industry
First posted
Feb 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to prove non-inferiority, as well as to demonstrate the comparability of safety and immunogenicity of RPH-051 and Perjeta® in combination with trastuzumab and docetaxel as the 1st line therapy for patients with HER2-positive breast cancer (BC). Secondary Purposes are to evaluate the pharmacokinetics of RPH-051 in comparison with Perjeta® after a single-dose and repeated intravenous administration

Conditions

  • Locally Advanced Breast Cancer
  • Metastatic Breast Cancer

Interventions

  • RPH-051Drug

    RPH-051: concentrate for solution for infusion, 30 mg/mL 14 mL of the liquid concentrate is diluted with 250 mL of 0.9% sodium chloride solution. The nominal concentration of the prepared solution is 3.0 mg/mL for the loading dose and 1.6 mg/mL for the maintenance dose

  • DocetaxelDrug

    Docetaxel: concentrate for solution for infusion, 20 mg/mL

  • Perjeta®Drug

    Perjeta®: concentrate for solution for infusion, 30 mg/mL 14 mL of the liquid concentrate is diluted with 250 mL of 0.9% sodium chloride solution. The nominal concentration of the prepared solution is 3.0 mg/mL for the loading dose and 1.6 mg/mL for the maintenance dose

  • TrastuzumabDrug

    Trastuzumab: lyophilisate for preparation of a concentrate for solution for infusion, 440 mg or 150 mg The contents of the vial (440 mg) are dissolved in 20 mL of bacteriostatic water for injection supplied with the drug, containing 1.1% benzyl alcohol. The contents of the vial (150 mg) are dissolved in 7.2 mL of sterile water for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective response rate (%) (ORR)Time frame: Up to day 126

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • State Budgetary Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Oncology Dispensary"

    Arkhangelsk, Russia

  • Regional State Budgetary Healthcare Institution "Altai Regional Oncology Dispensary"

    Barnaul, Russia

  • Private Healthcare Institution "RZD-Medicine Clinical Hospital of Chelyabinsk"

    Chelyabinsk, Russia

  • Regional Budgetary Healthcare Institution "Ivanovo Regional Oncology Dispensary" (RBHI "IvOOD")

    Ivanovo, Russia

  • State Budgetary Healthcare Institution of Kaluga Region "Kaluga Regional Clinical Oncology Dispensary"

    Kaluga, Russia

  • State Autonomous Healthcare Institution "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal"

    Kazan', Russia

  • State Budgetary Healthcare Institution "Kuzbass Clinical Oncology Dispensary named after M.S. Rappoport" (SBHI "KCOD")

    Kemerovo, Russia

  • Kirov Regional State Clinical Budgetary Healthcare Institution "Center of Oncology and Medical Radiology"

    Kirov, Russia

  • Regional State Budgetary Healthcare Institution "Krasnoyarsk Regional Clinical Oncology Dispensary named after A.I. Kryzhanovsky"

    Krasnoyarsk, Russia

  • State Budgetary Healthcare Institution of the City of Moscow "Moscow Multidisciplinary Clinical Center 'Kommunarka' of the Moscow Department of Healthcare" (SBHI "MMCC 'Kommunarka'")

    Moscow, Russia

  • Federal State Budgetary Institution "N.N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation

    Moscow, Russia

  • Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

    Moscow, Russia

  • Branch of the Limited Liability Company "Hadassah Medical Ltd." (LLC Branch "Hadassah Medical")

    Moscow, Russia

  • Federal State Autonomous Institution "National Medical Research Center 'Medical and Rehabilitation Center'" of the Ministry of Health of the Russian Federation

    Moscow, Russia

  • Limited Liability Company "RESEARCH LAB"

    Moscow, Russia

  • State Budgetary Healthcare Institution of the City of Moscow "City Clinical Hospital named after S.S. Yudin" of the Moscow Department of Healthcare

    Moscow, Russia

  • Joint-Stock Company "Medsi Group of Companies" (JSC "Medsi Group of Companies")

    Moscow, Russia

  • Federal State Budgetary Institution "N.N. Petrov National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation

    Moscow, Russia

  • Private Medical Institution "Euromedservice" (PMI "Euromedservice")

    Moscow, Russia

  • State Budgetary Healthcare Institution of the City of Moscow "Moscow Clinical Scientific and Practical Center named after A.S. Loginov of the Moscow Department of Healthcare"

    Moscow, Russia

  • Limited Liability Company "Novaya Liniya"

    Nal'chik, Russia

  • State Autonomous Healthcare Institution of the Nizhny Novgorod Region "Research Institute of Clinical Oncology 'Nizhny Novgorod Regional Clinical Oncology Dispensary'"

    Nizhny Novgorod, Russia

  • Limited Liability Company Medical and Sanitary Unit "Clinician-Pretor Clinic"

    Novosibirsk, Russia

  • Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of the Russian Federation

    Obninsk, Russia

  • Federal State Budgetary Healthcare Institution "Clinical Hospital No. 8 of the Federal Medical-Biological Agency" (FSBHI CH No. 8 FMBA)

    Obninsk, Russia

  • Budgetary Healthcare Institution of Omsk Region "Clinical Oncology Dispensary"

    Omsk, Russia

  • State Budgetary Healthcare Institution of Perm Krai "Perm Krai Oncology Dispensary"

    Perm, Russia

  • State Budgetary Healthcare Institution of Stavropol Krai "Pyatigorsk Interdistrict Oncology Dispensary"

    Pyatigorsk, Russia

  • Federal State Budgetary Institution "National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation

    Rostov-on-Don, Russia

  • Joint-Stock Company "Modern Medical Technologies"

    Saint Petersburg, Russia

  • Limited Liability Company "EuroCityClinic"

    Saint Petersburg, Russia

  • Federal State Budgetary Institution "N.N. Petrov National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation

    Saint Petersburg, Russia

  • State Budgetary Healthcare Institution "St. Petersburg Clinical Scientific and Practical Center for Specialized Medical Care (Oncology) named after N.P. Napalkov"

    Saint Petersburg, Russia

  • Saint Petersburg State Budgetary Healthcare Institution "City Clinical Oncology Dispensary" (SPB SBHI CCOD)

    Saint Petersburg, Russia

  • State Healthcare Institution "Regional Clinical Oncology Dispensary" (SHI "RCOD")

    Saratov, Russia

  • Regional State Budgetary Healthcare Institution "Smolensk Regional Oncology Clinical Dispensary"

    Smolensk, Russia

  • Federal State Budgetary Educational Institution of Higher Education "Siberian State Medical University" of the Ministry of Health of the Russian Federation

    Tomsk, Russia

  • Federal State Budgetary Scientific Institution "Tomsk National Research Medical Center of the Russian Academy of Sciences" (FSBSI "Tomsk NRMC of the Russian Academy of Sciences")

    Tomsk, Russia

  • State Healthcare Institution "Tula Regional Clinical Oncology Dispensary" (SHI "TRCOD")

    Tula, Russia

  • State Autonomous Healthcare Institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of the Republic of Bashkortostan

    Ufa, Russia

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.